Global Insulin Delivery Devices Market Outlook 2018
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Nov, 2014| No. of Pages : 120
1. Analyst View
2. Research Methodology
3. Global Insulin Market Overview to 2018
4. Industry Trends and Drivers
4.1 Rising Popularity of Artificial Pancreas
4.2 Home Infusion Therapy Gaining Importance in Treatment of Diabetes
4.3 Modifications in Insulin Delivery through Nanoparticles and Polymers
4.4 Increasing Prevalence of Diabetes
4.5 Rising Awareness among People about Diabetes Care
4.6 Improved Access and Lower Insulin Prices in the Developing World
4.7 Asian Markets Offer Considerable Growth Potential
5. Key Market Restraints
5.1 Risk and Complications Associated with Delivery of Insulin
5.2 High Cost of Insulin Analog
5.3 Traditional Remedies for Diabetes Care
6. Global Insulin Delivery Devices Market Outlook to 2018
6.1 US
6.1.1 Prevalence
6.1.2 Market Analysis
6.1.3 Regulatory Overview
6.2 Japan
6.2.1 Prevalence
6.2.2 Market Analysis
6.2.3 Regulatory Overview
6.3 China
6.3.1 Prevalence
6.3.2 Market Analysis
6.3.3 Regulatory Overview
6.4 Brazil
6.4.1 Prevalence
6.4.2 Market Analysis
6.4.3 Regulatory Overview
6.5 India
6.5.1 Prevalence
6.5.2 Market Analysis
6.5.3 Regulatory Overview
7. Insulin Delivery Devices: Current and Future Outlook to 2018
7.1 Insulin Pens
7.1.1 Mechanism and Technologies
7.1.2 Pros and Cons
7.1.3 Market Analysis
7.1.4 Key Players and Products
7.2 Insulin Pumps
7.2.1 Mechanism and Technologies
7.2.2 Pros and Cons
7.2.3 Market Analysis
7.2.4 Key Players and Products
7.3 Insulin Syringes
7.3.1 Mechanism and Technologies
7.3.2 Pros and Cons
7.3.3 Market Analysis
7.3.4 Key Players and Products
7.4 Insulin Jet Injectors
7.4.1 Mechanism and Technologies
7.4.2 Pros and Cons
7.4.3 Market Analysis
7.4.4 Key Players and Products
8. Emerging Devices
8.1 Implantable Insulin Pumps
8.2 Insulin Inhalers
8.3 Oral Insulin/Insulin Pill
8.4 Insulin Patch
9. Key Players
9.1 Novo Nordisk
9.2 Eli Lilly
9.3 Medtronic
9.4 Becton Dickinson
9.5 Sanofi-Aventis
9.6 F. Hoffmann La Roche
9.7 Insulet Corporation
9.8 Ypsomed Holding AG
9.9 Johnson and Johnson
9.10 B. Braun Melsungen AG
9.11 Abbott Laboratories